Skip to main content
Get the Weekly ESG Brief

West Pharmaceutical Services, Inc.

WSTNYSETrackedMarket Data VerifiedHealth CareHealth Care Supplies

Coverage
Coverage universe Identity published; no third-party ESG observation yet.
ESG profile reviewed
Last editorial update to this profile.
Quote
Last verified closeObservation time is shown beside the price.
Methodology
How we rateProvider ratings are shown separately, never blended.

Market overview

USD 370.44

Down−USD 3.16 (−0.85%) Day change

Last verified close · As of · USD · Market data via Massive Stock Widgets

The market is closed. This is the last verified closing quote, not an intraday price.

Open
USD 372.01
Previous close
USD 373.60
Day high
USD 372.14
Day low
USD 368.45
Volume
433,964
Market cap
USD 26,069,997,568
Price chart · 1 Year
West Pharmaceutical Services, Inc. 1 Year price chartWest Pharmaceutical Services, Inc., nyse:WST, 1 Year price chart in USD. Start USD 261.52, end USD 370.44, high USD 375.87, low USD 230.95, up.
Period1 YearFirst closeUSD 261.52Last closeUSD 370.44Maximum closeUSD 375.87Minimum closeUSD 230.95Period change+USD 108.92Period percentage change+41.65%Chart as ofSep 25, 2026, 1:30 PM GMT+0000
View Chart Data
Representative chart points — 24 of 251
Date and time Open High Low Close Volume
USD 254.99 USD 262.90 USD 254.76 USD 261.52 591,900
USD 276.85 USD 279.75 USD 271.18 USD 273.85 595,700
USD 278.39 USD 281.80 USD 274.88 USD 277.14 441,100
USD 272.26 USD 272.97 USD 265.39 USD 267.56 839,200
USD 274.54 USD 277.75 USD 273.90 USD 276.87 356,600
USD 275.62 USD 281.55 USD 272.81 USD 279.41 789,700
USD 230.90 USD 237.67 USD 228.83 USD 237.50 1,203,500
USD 233.84 USD 238.76 USD 228.00 USD 230.95 944,400
USD 243.90 USD 248.46 USD 243.89 USD 248.26 813,700
USD 245.53 USD 252.38 USD 242.92 USD 244.35 810,800
USD 238.85 USD 241.40 USD 236.12 USD 237.03 1,186,900
USD 253.90 USD 257.31 USD 251.46 USD 256.85 638,900
USD 278.00 USD 281.25 USD 273.88 USD 274.72 947,800
USD 311.31 USD 315.44 USD 308.18 USD 312.55 789,200
USD 308.17 USD 316.60 USD 304.80 USD 316.13 743,500
USD 317.43 USD 322.59 USD 315.24 USD 319.75 594,600
USD 335.72 USD 345.99 USD 335.72 USD 340.41 872,400
USD 357.92 USD 357.99 USD 352.70 USD 353.71 446,100
USD 329.24 USD 336.72 USD 325.27 USD 331.25 1,605,500
USD 353.89 USD 358.67 USD 351.52 USD 352.13 570,500
USD 353.75 USD 354.78 USD 348.22 USD 348.48 383,700
USD 333.57 USD 344.92 USD 331.99 USD 344.25 653,100
USD 370.93 USD 376.06 USD 368.20 USD 375.87 876,900
USD 372.01 USD 372.14 USD 368.45 USD 370.44 434,000

Company Profile & Business Model Overview

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Sustainability Strengths & Catalysts (Pros)

  • Critical injectables supplier
  • Biologics secular tailwind
  • High-quality recurring revenue

Material Risks & Governance Concerns (Cons)

  • Premium valuation
  • Customer concentration risk

Related ESG Peer Equities

Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.

Explore Health Care Peers →

ESG & Sustainability Rating Breakdown

Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.

Audited Methodology

Coverage PendingThird-Party ESG Coverage Under Review

Formal published scorecards from MSCI ESG Research and Sustainalytics are not currently available for this ticker. The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.

Data integrity and methodology

MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.

FAQ

Frequently Asked Questions

Direct answers on sustainability scores, risk methodologies, and peer rankings.

What is West Pharmaceutical Services, Inc. (WST)'s ESG rating and sustainability score?

Formal published scorecards from MSCI and Sustainalytics are under ongoing review for West Pharmaceutical Services, Inc. (WST). The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.

Is West Pharmaceutical Services, Inc. considered an ESG leader or laggard in Health Care?

Independent benchmark status for West Pharmaceutical Services, Inc. is evaluated relative to Health Care peers once third-party coverage publishes official methodology scores.

What are the main ESG risks and controversies for West Pharmaceutical Services, Inc.?

Key material risks for West Pharmaceutical Services, Inc. include: Premium valuation; Customer concentration risk. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.

How does The Impact Investor evaluate ESG stock profiles?

The Impact Investor presents audited third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.